VeloClub is CyclingTips’ membership program which brings us closer to our members, and connects likeminded cycling enthusiasts.
by Shane Stokes
December 19, 2017
Team LottoNL-Jumbo confirms Lobato’s departure, suspends Tolhoek and Eenkhoorn; MPCC calls on Sky to suspend Froome, wants UCI to investigate team TUE use; Doctor has serious concerns over Froome case; Dowsett ‘in tears’ after near miss with Porsche driver; Miguel Angel Lopez extends with Astana until 2020; Bresciani cleared to return to racing: rider had claimed mother’s tablet caused his doping positive; Hinault: Froome’s career could be over; Charity fundraising record set by Prudential RideLondon initiative; Inquest into death of ultra-endurance rider Mike Hall to be held in February; Video: Roadtripping Victoria’s High Country – Teaser; Video: Camille McMillan: Un-Lost Exhibition
When the news emerged in October that the Italian rider Michael Bresciani had tested positive for the diuretic furosemide, his explanation prompted many raised eyebrows. The Bardiani-CSF competitor said that his mother takes the blood pressure medication Lasix at mealtimes and, ‘in splitting the tablet, it must have ended up through force somewhere in my plate.’
The 22-year-old rider was was tested at the Italian national championships and the sample revealed the banned product. Ironically, he was brought onto the Bardiani team to help fill the gap after Nicola Ruffoni and Stefano Pirazzi tested positive for GH-Releasing Peptides.
However, although his explanation appeared to be implausible, Bresciani has been cleared to return to competition by the UCI. It stated via its list of anti-doping sanctions that he had been given a two month ban, expiring on October 10 2017. In August he had voluntarily agreed to suspend himself from racing. The short ban shows that the UCI believes there was no negligence on his part, indicating it accepted his explanation.
“With regard to today’s communication from Union Cycliste Internationale on Michael Bresciani, Bardiani-CSF express its satisfaction for the investigations’ outcome and the consequent decision that fully clears the rider from any accusations of fraudulent violations of anti-doping rules,” said his team.
“For Bardiani-CSF the UCI motivations prove that Bresciani has not violated any internal rules and team policy in terms of anti-doping, which declare the strong will to not have any riders in its roster with previous anti-doping violations not attributable to negligence and, in case of athletes under contract, their immediate dismissal. At the end, the team confirms that the precautionary suspension of Bresciani is finished and that Michael will be at disposal to face the 2018 race calendar.”